Results 181 to 190 of about 4,194,830 (297)

Preserving scientific integrity in academic publishing: Navigating artificial intelligence, journal policies, and the impact factor as a quality indicator. [PDF]

J Exp Orthop
Kayaalp ME, Zaffagnini S, Mont MA, Karlsson J, Reider B, Ayeni O, Heyse T, Madry H, Herbst E, Milano G, Musahl V, Becker R, Hirschmann MT.   +12 more
europepmc   +1 more source

Specialised Government Publishing: the Law Pocket and Linked Legal Data in the Netherlands

, 2016
Marc van Opijnen, Hayo Schreijer, Ilja Andreas, Maarten Kroon   +3 more
openalex   +2 more sources

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Synergizing Digital and Print: Leveraging Spine Surgeons' Social Media to Transform Publishing and Society Interaction. [PDF]

Int J Spine Surg
Burkhardt BW, Lewandrowski KU, Kim CW, Lorio MP, Alves OL, Fiorelli RKA, Schmidt SL, Yuan HA, Vaccaro AR.   +8 more
europepmc   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

AI-Generated Scientific Papers: Crisis? What Crisis? [PDF]

eNeuro
Bernard C.
europepmc   +1 more source

ASSESSMENT OF PROSPECTIVE ADVERSARIES IN DATA PUBLISHING

, 2014
Ch. Anjaiah, P. N. Vijaya Kumar, Dr.M.V. Siva Prasad   +2 more
openalex   +1 more source

Publishing and Long-Term Archiving 3D Data in Humanities [PDF]

Matthieu Quantin, Sarah Tournon, Mehdi Chayani, Xavier Granier, Florent Laroche   +4 more
openalex   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

ChatGPT-4.0 as a Tool for Automated Review of Ethics and Transparency in Biomedical Literature. [PDF]

J Korean Med Sci
Doskaliuk B, Seiil B, Qumar A.
europepmc   +1 more source